Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Reichlin Vogt
A growing body of evidence raises concerns about the scientific validity and reproducibility of published research findings due to the substantial risk of bias in preclinical animal studies. Systematic reviews discovered poor reporting rates of bias prevention techniques (such as randomization, blinding, and sample size calculation) in the published literature and a link between these low reporting rates and exaggerated treatment effects. It might be possible to identify bias risks sooner, before the research has been conducted, if the majority of animal research were subject to ethical or peer review. For instance, animal studies are authorised in Switzerland based on a harm-benefit analysis and a full explanation of the study procedure. Therefore, we compared the reporting rates of the same measures in a representative sub-sample of publications (n = 50) with the rates at which the use of seven basic measures against bias (allocation concealment, blinding, randomization, sample size calculation, inclusion/exclusion criteria, primary outcome variable, and statistical analysis plan) were described in applications for animal experiments submitted to Swiss authorities (n = 1,277). In applications for animal experiments, measures against bias were disclosed at extremely low rates, ranging on average from 2.4% for the statistical analysis plan to 19% for the primary outcome variable, and from 0.0% for the calculation of the sample size to 34% for the statistical analysis plan in publications from these experiments. We found a weak positive correlation between the internal validity scores (IVS) of publications and applications (Spearman’s rho = 0.34, p = 0.014), indicating that the rates of describing these measures in applications partially predict their rates of reporting in publications. The IVS was calculated based on the proportion of the seven measures against bias. These findings suggest that key information about experimental design, which establishes the scientific validity of the findings, is missing from the authorities licencing animal experiments. This information may be crucial for the weight given to the research’s benefits in the harm-benefit analysis. Applications for animal experiments may frequently be allowed based on implicit confidence rather than explicit evidence of scientific rigour, similar to articles getting accepted for publication despite poor reporting of measures against bias. Our results cast considerable doubt on the peer-review process for scientific publications as well as the current authorization process for animal studies, which over time may damage the validity of research. One viable method to change the system is to transition from the authorization processes that are already in place in many nations to a preregistration system for animal research. This would help to prevent needless harm to animals for fruitless research as well as improve the scientific quality of data from animal trials.
Author synopsis
Scientific rigour, which includes steps to prevent bias, such as randomising the assignment of animals to treatment groups and evaluating outcome measures without being aware of the treatment groups to which the animals belong, is necessary for the scientific validity of research findings (blinding). The systematic studies indicated that inadequate reporting was linked to greater treatment effects, indicating bias, and that safeguards against bias are infrequently reported in publications. Here, we looked into the possibility of predicting bias risk from study protocols submitted for ethical review. In study protocols submitted for approval in Switzerland as well as in publications emerging from these studies, we looked for mention of seven fundamental precautions against bias. Both in study procedures (2%-19%) and in publications (0%-34%), measures against bias were indicated at very low rates. The rates at which measures against bias were specified in study protocols predicted the rates at which they were reported in publications, according to a weakly positive connection that we discovered. Our findings show that the approval of animal studies is frequently based more on scientific rigour than on evidence of confidence, which may impair the validity of the research and cause undue injury to the animals.